Chronic Weight Management/Obesity Tools & Resources For Employers

Published 10/07/2022

This list of resources is intended for employers and contains: Relevant tools employers can immediately access to help them better understand how to actively engage their employees around chronic weight management Specific guides, websites, suggestions, and best practices from organizations leading the way with comprehensive benefits including how to address stigma and bias, ERGs, and step by...

COVID-19 Immunization Video Series

Published 03/31/2021

The National Alliance has created a COVID-19 immunization video series for employees/patients. All of the videos have received the endorsement of the CDC and National Medical Director Advisory Council.  COVID-19 Get the Facts (with Spanish subtitles) COVID-19 Get the Facts The History of Vaccines The History of Vaccines(with Spanish Subtitles) Trusting Vaccines Trusting Vaccines (with Spanish Subtitles)

Provisions in the Consolidated Appropriations Act of 2020

Published 02/25/2021

On December 27, 2020, President Trump signed the Consolidated Appropriations Act, which funds the government through September 30, 2021.  The $1.4 trillion legislation includes approximately $900 billion in COVID relief, and several significant health care provisions. Click here to read the latest Health Policy in Transit Brief from the National Alliance of Healthcare Purchaser Coalitions. 

Findings from RAND 3.0

Published 09/22/2020

Nationwide Evaluation of Health Care Prices Paid by Private Health Plans Findings from Round 3 of an Employer-Led Transparency Initiative by Christopher M. Whaley, Brian Briscombe, Rose Kerber, Brenna O'Neill, Aaron Kofner Related Topics: Employer Sponsored Health Insurance, Health Care Cost Inflation, Hospitals, Measuring Health Care Costs, Medicare In the United States, low levels of price transparency make it hard for employers and other...

Biosimilars in the Pharmacy Benefit

Published 07/03/2020

Despite the fact that less than 2% of the US population uses biologic drugs, they account for 26% of national prescription drug spending. Biosimilars can expand options, enhance affordability, and increase access to therapy. It’s been estimated that biosimilars could save patients and the healthcare system from $54 to $250 billion over their first 10...